Archives
-
Cy5 TSA Fluorescence System Kit: Evidence in Context
2026-10-04
The Cy5 TSA Fluorescence System Kit can make scarce molecular signals more visible, but amplification does not independently establish biological causality. This article examines how horseradish peroxidase catalyzed tyramide deposition could support spatial interpretation of intestinal repair research while separating product claims from evidence reported in a 2026 FASEB Journal study.
-
TRIM66 and the One-Neuron–One-Receptor Rule
2026-10-03
A 2025 Nature Communications study identifies TRIM66 as an epigenetic repressor that helps mature olfactory sensory neurons silence surplus receptor genes and maintain monogenic receptor expression. The findings connect enhancer repression with neural activity and innate olfactory behavior, while also defining important boundaries around developmental context, causality, and transferability beyond the mouse olfactory system.
-
Geneticin (G418 Sulfate): Selection Workflows
2026-10-02
Build more reliable engineered cell lines with practical Geneticin kill-curve, selection, and maintenance workflows. The same reagent also supports carefully controlled Dengue virus inhibition studies, provided cytotoxicity and antiviral effects are separated experimentally.
-
2-NBDG for Cellular Glucose Uptake Assays
2026-10-01
2-NBDG provides a flexible fluorescent readout for transporter-mediated glucose uptake across flow cytometry, microscopy, and plate-based workflows. This guide translates the ROS/NF-κB/HK2 findings in arsenic-exposed hepatocytes into practical assay design, kinetic optimization, and troubleshooting decisions.
-
Tacrolimus (FK506) at the Calcineurin–Stress Interface
2026-10-01
Tacrolimus (FK506) is a potent calcineurin inhibitor for dissecting T-cell cytokine signaling and immune response suppression. This article adds a distinct assay perspective by separating calcineurin biology from the AMPK–SQSTM1 stress-adaptation circuitry described in recent research.
-
BRD4–RAC1 Co-targeting in Breast Cancer
2026-09-30
The reference study identifies combined BRD4 and RAC1 inhibition as a context-dependent strategy that suppresses breast cancer growth, migration, stem-like properties, and xenograft tumorigenesis. Its mechanistic contribution is to connect dual pathway inhibition with disruption of the c-MYC–G9a–FTH1 axis and downregulation of HDAC1-associated chromatin regulation.
-
5-Methoxy-UTP: Evidence and Workflow Guide
2026-09-30
5-Methoxy-UTP is a modified uridine triphosphate research reagent whose incorporation, RNA effects, and delivery performance require direct validation. The cited LNP study supports formulation-aware modeling, but it does not establish 5-Methoxy-UTP activity or compatibility.
-
Asunaprevir: Designing Mechanism-Linked HCV Assays
2026-09-29
Asunaprevir (BMS-650032) is a potent HCV NS3/4A protease inhibitor with broad genotype activity. This guide focuses on mechanism-linked assay design, orthogonal validation, and the limits of translating unrelated chromatin-screen findings into hepatitis C research.
-
YAP–TEAD Super-Enhancers in Ectoderm Commitment
2026-09-29
Wang and colleagues map how super-enhancer networks shape early surface ectoderm commitment from pluripotent stem cells and identify YAP–TEAD as a central regulatory module. Their combination of three-dimensional genome analysis, enhancer perturbation, and transcription-factor network reconstruction provides a mechanistic framework for studying epithelial lineage specification and regenerative biology.
-
Cy3 Goat Anti-Mouse IgG (H+L) Antibody Guide
2026-09-28
The Cy3 Goat Anti-Mouse IgG (H+L) Antibody provides fluorescent detection of mouse primary antibodies in immunofluorescence, flow cytometry, and western blot workflows. This guide explains handling, titration, controls, and troubleshooting while noting that assay-specific dilution, cross-reactivity, and performance must be validated experimentally.
-
SCP4, H3T3 Dephosphorylation, and Chromosome Stability
2026-09-28
The study identifies nuclear phosphatase SCP4 as a regulator that removes mitotic histone H3 Thr3 phosphorylation, helping control chromosomal passenger complex recruitment and chromosome segregation. Cell and mouse-zygote findings connect disrupted SCP4 activity with mitotic errors and aneuploidy, while leaving important questions about regulation and context for future work.
-
Ibrexafungerp Against Fluconazole-Resistant C. auris
2026-09-27
Wiederhold and colleagues found that ibrexafungerp inhibited all 54 tested Candida auris isolates in vitro and improved survival and kidney fungal burden in a neutropenic mouse model when therapy began 24 hours after infection. The results support further study of oral glucan-synthesis inhibition for resistant invasive candidiasis, while remaining preclinical evidence rather than proof of clinical efficacy.
-
Murine RNase Inhibitor for RNA Mapping Workflows
2026-09-26
Protect RNA during reverse transcription and other sensitive steps without treating every nuclease as the same target. This workflow-focused guide explains where Murine RNase Inhibitor can support SHAPE-seq and related assays—and where adding an inhibitor could interfere with the experiment.
-
GSTA1 Drives Glutathione Loss in α-Amanitin Liver Injury
2026-09-25
The study identifies GSTA1 as an unexpected contributor to α-amanitin-induced liver injury: rather than protecting hepatocytes, increased GSTA1 was associated with glutathione depletion, oxidative stress, and cell damage. Its combination of mouse injury models, multi-omics, target-interaction assays, and GSTA1 silencing offers a mechanistic framework for testing this finding, while leaving important questions about pathway details and clinical relevance open.
-
Potassium Iodide: Research Workflows & Use Cases
2026-09-25
Use Potassium Iodide as a defined iodide input for thyroid-focused research, with practical guidance on solution preparation, exploratory dosing, and assay controls. The featured immunotherapy study offers a useful delivery-design case study—but does not test KI, so the article keeps those applications clearly distinct.